نتایج جستجو برای: cancer dual targeting nanobody nrp

تعداد نتایج: 1169826  

2013
Christina G Siontorou

The discovery of naturally occurring, heavy-chain only antibodies in Camelidae, and their further development into small recombinant nanobodies, presents attractive alternatives in drug delivery and imaging. Easily expressed in microorganisms and amenable to engineering, nanobody derivatives are soluble, stable, versatile, and have unique refolding capacities, reduced aggregation tendencies, an...

Journal: :The Journal of Cell Biology 1998
Tae-Aug Kim Jinkyu Lim Setsuo Ota Sandhya Raja Rick Rogers Benjamin Rivnay Hava Avraham Shalom Avraham

The nuclear matrix is defined as the insoluble framework of the nucleus and has been implicated in the regulation of gene expression, the cell cycle, and nuclear structural integrity via linkage to intermediate filaments of the cytoskeleton. We have discovered a novel nuclear matrix protein, NRP/B (nuclear restricted protein/brain), which contains two major structural elements: a BTB domain-lik...

2012
Ingo Schubert Christoph Stein Georg H. Fey

Here we review recombinant proteins with a capability for dual-targeting. These molecules address two different antigens on the same tumor cell and therefore are called “dual-targeting agents”. By virtue of binding a chosen pair of antigens on the malignant cell, preferential binding to antigen double-positive over single-positive cells can be achieved when both are present in the same environm...

2013
Neil Patel Neil D. Patel

Mycobacterium tuberculosis is responsible for nearly 2 million deaths yearly. Upon inhalation, mycobacteria are engulfed by alveolar macrophages. These cells produce reactive oxygen and nitrogen intermediates (ROI’s and RNI’s), which normally kill pathogens, but are ineffective against invading mycobacteria. What ensues, is the formation of a tubercle to sequester the infected macrophages, and ...

2014
Ivana Jovčevska Neja Zupanec Nina Kočevar Daniela Cesselli Neža Podergajs Clara Limbaeck Stokin Michael P. Myers Serge Muyldermans Gholamreza Hassanzadeh Ghassabeh Helena Motaln Maria Elisabetta Ruaro Evgenia Bourkoula Tamara Lah Turnšek Radovan Komel

Malignant gliomas are among the rarest brain tumours, and they have the worst prognosis. Grade IV astrocytoma, known as glioblastoma multiforme (GBM), is a highly lethal disease where the standard therapies of surgery, followed by radiation and chemotherapy, cannot significantly prolong the life expectancy of the patients. Tumour recurrence shows more aggressive form compared to the primary tum...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2015
Ying Wang Ying Cao Satsuki Yamada Mahesh Thirunavukkarasu Veronica Nin Mandip Joshi Muhammed T Rishi Santanu Bhattacharya Juliana Camacho-Pereira Anil K Sharma Khader Shameer Jean-Pierre A Kocher Juan A Sanchez Enfeng Wang Luke H Hoeppner Shamit K Dutta Edward B Leof Vijay Shah Kevin P Claffey Eduardo N Chini Michael Simons Andre Terzic Nilanjana Maulik Debabrata Mukhopadhyay

OBJECTIVE Neuropilin-1 (NRP-1) is a multidomain membrane receptor involved in angiogenesis and development of neuronal circuits, however, the role of NRP-1 in cardiovascular pathophysiology remains elusive. APPROACH AND RESULTS In this study, we first observed that deletion of NRP-1 induced peroxisome proliferator-activated receptor γ coactivator 1α in cardiomyocytes and vascular smooth muscl...

Journal: :Advanced Healthcare Materials 2022

Nanomedicines In article 2201140 by Hsin-Cheng Chiu and co-workers, an oral polysaccharide microgel formulation containing dual-modality therapeutic nanoparticles developed for local treatment of colon cancer is imparted to hierarchical targeting residues, leading increases in retention cell uptake nanotherapeutics. With enzymatic degradation dextran microgels occurring exclusively the colon, n...

2017
Elie Dheilly Valéry Moine Lucile Broyer Susana Salgado-Pires Zoë Johnson Anne Papaioannou Laura Cons Sébastien Calloud Stefano Majocchi Robert Nelson François Rousseau Walter Ferlin Marie Kosco-Vilbois Nicolas Fischer Krzysztof Masternak

CD47 is a ubiquitously expressed immune checkpoint receptor that is often upregulated in cancer. CD47 interacts with its counter-receptor SIRPα on macrophages and other myeloid cells to inhibit cancer cell phagocytosis and drive immune evasion. To overcome tolerability and "antigen sink" issues arising from widespread CD47 expression, we generated dual-targeting bispecific antibodies that selec...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید